Bristol-Myers Squibb Company (BMY) Stock Overview
NYSE · Healthcare · Drug Manufacturers - General
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for…
Source: Yahoo Finance
Sector & Industry
Bristol-Myers Squibb Company operates in the Healthcare sector, within the Drug Manufacturers - General industry group. It is listed on the NYSE exchange.
Bristol-Myers Squibb Company at a Glance
| Company | Bristol-Myers Squibb Company |
| Ticker | BMY |
| Exchange | NYSE |
| Currency | USD |
| Price | $66.82 |
| Market cap | $136.49B |
| P/E ratio (trailing) | 14.72 |
| EPS (trailing) | $4.54 |
| 52-week high | $68.64 |
| 52-week low | $42.52 |
| Dividend yield | 3.77% |
| Ex-dividend date | 02 Jul 2026 |
| Beta | 0.23 |
| Return on equity (ROE) | 46.60% |
| Debt-to-equity | 201.86% |
| Average volume | 11.39M |
| Shares outstanding | 2.04B |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Employees | 32,500 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Frequently Asked Questions
- What is Bristol-Myers Squibb Company's current P/E ratio?
- Bristol-Myers Squibb Company (BMY) has a trailing P/E ratio of 14.72 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Bristol-Myers Squibb Company's market capitalisation?
- Bristol-Myers Squibb Company's market cap is $136.49B based on our latest snapshot. See how it ranks by market cap →
- What is BMY's 52-week range?
- Over the past 52 weeks, BMY has traded between $42.52 and $68.64. What does the 52-week range mean? →
- How volatile is Bristol-Myers Squibb Company compared to the market?
- Bristol-Myers Squibb Company has a beta of 0.23, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Bristol-Myers Squibb Company pay a dividend?
- Bristol-Myers Squibb Company's trailing annual dividend yield is 3.77%. Compare with other high-yield stocks →
- What exchange is BMY listed on?
- BMY is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is Bristol-Myers Squibb Company in?
- Bristol-Myers Squibb Company is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →